Cosmetic Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 14/202,840, filed Mar 10, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,111,919 | Cosmetic Compositions In force · High confidence | Allustra Technologies LLC | In force | High confidence | ||
| US 10,842,837 | Cosmetic Compositions In force · High confidence | Allustra Technologies LLC | In force | High confidence | ||
| US 12,048,723 | Cosmetic Compositions In force · High confidence | Allustra Technologies LLC | In force | High confidence | ||
| US 11,547,733 | Cosmetic Compositions In force · High confidence | Allustra Technologies LLC | In force | High confidence | ||
| US 12,788,791 | Cosmetic Compositions In force · High confidence | Mary Kay Inc. | In force | High confidence | ||
| US 9,333,230 | Cosmetic Compositions Lapsed May 10, 2024 on the fee record Ended May 10, 2024 · High confidence | Allustra Technologies LLC | Lapsed May 10, 2024 on the fee record | Ended May 10, 2024 | High confidence |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Mary Kay Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.